CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,086,417 | -17.4% | 244,248 | +2.1% | 0.00% | -33.3% |
Q2 2023 | $13,426,612 | +49.3% | 239,163 | +20.3% | 0.00% | +50.0% |
Q1 2023 | $8,995,072 | +17.3% | 198,874 | +5.4% | 0.00% | 0.0% |
Q4 2022 | $7,668,297 | -41.0% | 188,642 | -5.1% | 0.00% | -33.3% |
Q3 2022 | $12,990,000 | +16.0% | 198,764 | +7.9% | 0.00% | +50.0% |
Q2 2022 | $11,195,000 | +7.7% | 184,231 | +11.2% | 0.00% | 0.0% |
Q1 2022 | $10,395,000 | +216.7% | 165,610 | +282.4% | 0.00% | +100.0% |
Q4 2021 | $3,282,000 | -30.7% | 43,308 | +2.4% | 0.00% | 0.0% |
Q3 2021 | $4,735,000 | -44.3% | 42,301 | -19.4% | 0.00% | 0.0% |
Q2 2021 | $8,497,000 | +16.5% | 52,481 | -12.3% | 0.00% | 0.0% |
Q1 2021 | $7,295,000 | -0.6% | 59,875 | +25.0% | 0.00% | 0.0% |
Q4 2020 | $7,336,000 | +93.2% | 47,913 | +5.5% | 0.00% | 0.0% |
Q3 2020 | $3,798,000 | +29.0% | 45,413 | +13.3% | 0.00% | 0.0% |
Q2 2020 | $2,945,000 | +92.4% | 40,069 | +11.0% | 0.00% | – |
Q1 2020 | $1,531,000 | -26.2% | 36,093 | +6.0% | 0.00% | – |
Q4 2019 | $2,074,000 | +59.5% | 34,054 | +7.3% | 0.00% | – |
Q3 2019 | $1,300,000 | -11.1% | 31,733 | +2.1% | 0.00% | – |
Q2 2019 | $1,463,000 | +41.6% | 31,078 | +7.6% | 0.00% | – |
Q1 2019 | $1,033,000 | +62.9% | 28,890 | +30.1% | 0.00% | – |
Q4 2018 | $634,000 | -49.5% | 22,207 | -21.6% | 0.00% | – |
Q3 2018 | $1,255,000 | -11.4% | 28,317 | +17.4% | 0.00% | – |
Q2 2018 | $1,417,000 | +95.2% | 24,121 | +51.9% | 0.00% | – |
Q1 2018 | $726,000 | – | 15,880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |